Product Information

RAMIPRIL 2.5 MG CAPSULE is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0508 per EA under NDC 76282067101. Its NADAC has been published 336 times since Jun 17, 2020.

FDA first approved this application on Jun 18, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RAMIPRIL 2.5 MG CAPSULE

Ramipril
$0.0508per EA

Strength

2.5 mg/1

NDC

76282067101

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

RAMIPRIL

Approval Type

Generic (ANDA)

FDA Application

ANDA077900

FDA Approved

6/18/2008

TE Code

AB

On Market Since

6/18/2008

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for RAMIPRIL 2.5 MG CAPSULE has been published 336 times since Jun 17, 2020, and over the history we have for it it has declined 28.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0508 per EA
All-time high$0.0755 (Nov 11, 2020)
All-time low$0.0425 (May 22, 2024)
52-week high$0.0578
52-week low$0.0460
Median price$0.0591
Average price$0.0594
Largest weekly change-26.5% (Jan 17, 2024)
Weeks tracked336
Tracking sinceJun 17, 2020

Price History

1W

+2.8%

1M

+7.3%

3M

+10.3%

6M

-4.4%

1Y

-10.6%

3Y

-16.7%

5Y

-23.7%

All

-28.5%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RAMIPRIL 2.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 2.5 MG CAPSULE, manufactured by Exelan Pharmaceuticals Inc., is $0.0508 per EA (NDC 76282067101), effective Nov 18, 2026.

How has the price of RAMIPRIL 2.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RAMIPRIL 2.5 MG CAPSULE has declined 28.5%. It has been tracked across 336 weekly CMS publications since Jun 17, 2020.

What are the highest and lowest recorded NADAC prices for RAMIPRIL 2.5 MG CAPSULE?

Since Jun 17, 2020, the NADAC for RAMIPRIL 2.5 MG CAPSULE has ranged from a low of $0.0425 (May 22, 2024) to a high of $0.0755 (Nov 11, 2020), with a median of $0.0591 per EA.

Are there cheaper alternatives to RAMIPRIL 2.5 MG CAPSULE?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RAMIPRIL 2.5 MG CAPSULE, is $0.0460 per EA — about 9% below RAMIPRIL 2.5 MG CAPSULE.

Who manufactures RAMIPRIL 2.5 MG CAPSULE?

RAMIPRIL 2.5 MG CAPSULE (NDC 76282067101) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.